NDC 0078-0713 – Jadenu
Deferasirox 180 mg/1 · Granule · Oral
Product NDC0078-0713
Product details
- Brand name
- Jadenu
- Generic name
- deferasirox
- Labeler
- Novartis Pharmaceuticals Corporation
- Dosage form
- Granule
- Route
- Oral
- Marketing category
- NDA · NDA207968
- Marketed since
- May 18, 2017
- Listing expires
- December 31, 2026
- Pharmacologic class
- Iron Chelator
Active ingredients
- Deferasirox 180 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0078-0713-15 | 30 PACKET in 1 CARTON (0078-0713-15) / 1 GRANULE in 1 PACKET (0078-0713-19) | May 18, 2017 |
Other Jadenu products
- 0078-0654 Deferasirox 90 mg/1 · Tablet, Film Coated · Novartis Pharmaceuticals Corporation
- 0078-0655 Deferasirox 180 mg/1 · Tablet, Film Coated · Novartis Pharmaceuticals Corporation
- 0078-0656 Deferasirox 360 mg/1 · Tablet, Film Coated · Novartis Pharmaceuticals Corporation
- 0078-0720 Deferasirox 360 mg/1 · Granule · Novartis Pharmaceuticals Corporation
- 0078-0727 Deferasirox 90 mg/1 · Granule · Novartis Pharmaceuticals Corporation